SAMSUNG BIOLOGICS SAW ITS Q1 NET PROFIT TO RISE BY 66.4%

Highlights –

• Samsung Biologics saw its Q1 net profit to rise by 66.4%.
• During January-April period the company’s net profit reached US$54.8 million.
• In the same period its operating profit rose 74.3 billion won.
• On Wednesday trading on the Seoul bourse, the company’s share fell 1.98% to close at 791,000 won.

South Korea's top conglomerat....